Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Advanced Primary Liver Cancer × lenvatinib × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Liver Neoplasms 1 Genital Neoplasms, Female 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Advanced Primary Liver Cancer 1 Adrenocortical Carcinoma 1

Interventions

lenvatinib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05411757 2022-06-09

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Shandong Public Health Clinical Center

Phase EARLY_PHASE1 Unknown

Advanced Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡